Shannon Resetich | Global Franchise Head, Rare Diseases
Sanofi Genzyme

Shannon Resetich, Global Franchise Head, Rare Diseases, Sanofi Genzyme

Appearances:

World Orphan Drug Congress USA 2022 - Day 1 @ 09:00

Keynote Fireside-chat: State of global rare ecosystem – leveraging public private partnerships to further shape the future or rare diseases around the world

Moderator: Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)

Shannon Resetich, Global Franchise Head, Rare Diseases, Sanofi Genzyme

Fumie Griego, Deputy Director General And Chief Operating Officer, International Federation of Pharmaceutical Manufacturers and Associations

Durhane Wong-Rieger, President & Chief Executive Officer, Canadian Organization for Rare Disorders

last published: 29/Jun/22 01:45 GMT

back to speakers

Get Involved At World Orphan Drug Congress USA

To Sponsor Or Exhibit

Justin Franks
justin.franks@terrapinn.com
t/ +1 914 819 3506

To Speak

Claire Murphy
claire.murphy@terrapinn.com
t/ +1 646 619 1784

Marketing & Press Opportunities

Taylor Post
taylor.post@terrapinn.com
t/ +1 646 619 1785